Cth/Mpst double ablation results in early onset fatty liver disease in lean mice
Redox Biology · 2025
DOI: 10.1016/j.redox.2025.103641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2025. Verfasst von Antonia Katsouda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Division o…. Hauptthemen laut MEDLINE: Fatty Liver, Sulfurtransferases, Cystathionine gamma-Lyase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National and Kapodistrian University of Athens, European Commission.
Abstract (Originalsprache)
Metabolic dysfunction-associated fatty liver disease (MAFLD), a condition that stems from hepatic lipid accumulation in the absence of liver damage and overt inflammation, has become the most common hepatic disorder worldwide. Hydrogen sulfide (H2S), a gasotrasmitter, endogenously generated mainly by cystathionine-γ lyase (CTH), cystathionine-β synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (MPST) enzymes, exhibits protective effect in steatosis. Herein, we have demonstrated that CTH and MPST play a central role in MAFLD pathogenesis. Young Cth/Mpst knockout (Cth/Mpst-/-) mice, fed a normal diet, had increased liver mass caused by enhanced hepatic lipid accumulation. Decreased insulin and glucose sensitivity was observed in CTH/MPST-deficient mice. At the cellular level, CTH/MPST inhibition resulted in increased lipid deposition and glucose uptake in hepatocytes. Transcriptome analysis revealed significant upregulation of cholesterol biosynthesis and SREBP-related genes in the liver of Cth/Mpst-/- mice. Transcription factor enrichment analysis of differentially expressed genes between two genotypes, revealed a major impact of LXR, RXR and PPARA in the observed phenotype. Sulfide donor (SG1002) treatment attenuated the fatty liver disease of CTH/MPST-deficient mice. Our findings underline the importance of endogenously produced H2S in the pathogenesis of MAFLD and introduce the Cth/Mpst-/- mouse as a new animal model of early onset hepatic steatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Universit…
- Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian Unive…
- Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Förderung
- National and Kapodistrian University of Athens
- European Commission
Zitieren
APA
Katsouda, A., Markou, M., Valakos, D., Theodorou, I., & Papapetropoulos, A. (2025). Cth/Mpst double ablation results in early onset fatty liver disease in lean mice. Redox Biology. https://doi.org/10.1016/j.redox.2025.103641
Vancouver
Katsouda A, Markou M, Valakos D, Theodorou I, Papapetropoulos A. Cth/Mpst double ablation results in early onset fatty liver disease in lean mice. Redox Biology. 2025. doi:10.1016/j.redox.2025.103641
BibTeX
@article{Katsouda2025,
author = {Katsouda, Antonia and Markou, Maria and Valakos, Dimitrios and Theodorou, Ioannis and Papapetropoulos, Andreas},
title = {Cth/Mpst double ablation results in early onset fatty liver disease in lean mice},
journal = {Redox Biology},
year = {2025},
doi = {10.1016/j.redox.2025.103641}
}
EUVIMED